ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 157365 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 157365; 2) Community: the network communities that were significantly associated with the response to NSC 157365; 3) Molecule: the relationships between components within communities and NSC 157365; 4) MDR: the compounds that were significantly associated with the NSC 157365.

NSC Compound Enrichment Correlation
NSC 734949 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide 0.021946808377072 0.2708246
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.021946808377072 0.4034612
NSC 627991 Benzo[g]pteridine-2,4-dione, 8-chloro-10-(4-chlorophenyl)- 3-methyl- 0.0219468083770722 0.17229528
NSC 716535 Null 0.0219468083770722 0.10957326
NSC 295501 Camptothecin Derivative 0.0287230216965525 0.3386304
NSC 625543 ANTINEOPLASTIC-625543 0.0287230216965525 0.0365907
NSC 626673 Null 0.0287230216965525 0.24766138
NSC 639512 Cyclopentanone, 2-[(4-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0287230216965525 0.17597618
NSC 639662 Miltirone 0.0287230216965525 0.1550834
NSC 645808 Null 0.0287230216965525 0.42184044
Total:34  Current:15    [First] [Prev] [Next] [Last]